EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered into a new, five-year credit agreement with MidCap Financial (“MidCap”), comprised of up to $100 million in term loans and a $25 […]
Author: Ken Dropiewski
Medtronic first to receive FDA approval for pacing the heart’s natural conduction system
Medtronic “conduction system pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates DUBLIN, Oct. 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for […]
World’s first digital SPECT/CT capable of high energy imaging enables full range of clinical capabilities to Nuclear Medicine Centers across the world.
Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine. SARASOTA, Fla, Oct. 16, 2022 /PRNewswire/ — Spectrum Dynamics today announced its newest development in digital nuclear medicine imaging: the capability to […]
New Initiative to Prevent, Treat and Beat Stroke Focuses on Health Equity, Heart-brain Connection
The American Heart Association’s Getting to the Heart of Stroke™ initiative, developed in conjunction with and supported by HCA Healthcare and the HCA Healthcare Foundation, focuses on preventing, treating and beating stroke by providing consumer and health care professional education nationwide, deepening collaboration between neurology and cardiology and equitably empowering communities […]
Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery
Dr. Johnston will serve as chief of cardiac surgery and surgical director of Bluhm Cardiovascular Institute CHICAGO, Oct. 13, 2022 /PRNewswire/ — Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School […]
Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
The HELIOSTAR™ Balloon Ablation Catheter’s unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution1 IRVINE, Calif., Oct. 13, 2022 /PRNewswire/ — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation […]
Fountain Life Appoints Rakesh M. Suri, M.D., D.Phil., as President and Chief Medical Officer
Prominent Cardiac Surgeon and Former Cleveland Clinic Leader to Drive Global Growth of Preventative Health Company NAPLES, Fla., Oct. 13, 2022 /PRNewswire/ — Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Rakesh M. Suri, M.D., D.Phil., as the company’s […]
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic System, the first disposable robotic system being developed for endovascular procedures. The study was performed by a team of seasoned Key […]
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
DANVERS, Mass.–(BUSINESS WIRE)–An analysis of more than 2,000 patients from a large U.S. real-world database finds that patients who underwent a non-emergent high-risk PCI with the Impella heart pump (n=1,447) had significantly improved survival, reduced myocardial infarction, reduced cardiogenic shock after PCI and shorter length of stay than matched patients treated with […]
Treatment of Severe Heart Failure – AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER® First-In-Human Trials
ICOMS FLOWMAKER®, First Fully Implantable Electro-Physiological Cardiac Assistance Device Guillaume Buc, Chief Technical Officer Sophie Jonquière, Chief Procurement & Supply Chain Officer BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet […]



